MedPath

Pilot study of dMD-002 in patients with neurovascular bundles injury during radical prostatectomy

Not Applicable
Conditions
Prostate cancer
Registration Number
JPRN-jRCT2022210040
Lead Sponsor
akamura Masaki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Male
Target Recruitment
12
Inclusion Criteria

(1) Patients diagnosed with prostate cancer
(2) Patients scheduled for radical prostatectomy (non-nerve sparing or unilateral nerve-sparing) by robot-assisted laparoscopic surgery
etc.

Exclusion Criteria

(1) Patients required radiation therapy, endocrine therapy or antineoplastic therapy before or after radical prostatectomy
(2) Patients taking PDE5 inhibitors
(3) Patients using negative pressure erection apparatus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy<br> Change in EHS<br> Change in IIEF EF<br> Change in EPIC sxual function(Q17 to 23)<br><br>Safety<br> Advere event<br> defect
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath